Blood cell diagnosis startup Noul was acknowledged at the 2019 Grand Challenges Annual Meeting for its innovative Malaria diagnosis solution, miLab, the company said Wednesday.

The Grand Challenges Meeting is an annual gathering of global organizations promoting global health care. This year’s event held in Addis Ababa, the capital city of Ethiopia, was co-hosted by the African Union, Ethiopia’s Ministry of Health, Grand Challenges Canada, the United States Agency for International Development and the Bill & Melinda Gates Foundation. 

Korean companies participating in Korea International Cooperation Agency’s Creative Technology Solution project attended the event.

Noul, a startup founded in 2015, has been invited to the Grand Challenges Meeting every year since its foundation.

At this year’s meeting, the firm showcased its diagnostics solution for Malaria in a poster presentation and was awarded the people’s choice award for best presentation.

MiLab’s Malaria diagnostics empower people in resource-limited settings to conduct morphology-based Malaria diagnoses without costly infrastructure investment and trained lab technicians.

The core technology in the miLab contains the patented Next Generation Staining and Immunoassay technology (NGSI) enabling full automation of the entire testing process from the sample slide preparation to highly accurate diagnosis by artificial intelligence.

MiLab is expected to launch in mid-2020.

By Lim Jeong-yeo (kaylalim@heraldcorp.com)